2020-2029 Report on Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market by Player, Region, Type, Application and Sales Channel
- Report Code : MAR2141228
- Published On: Nov, 2020
- Category : Healthcare & Pharma
- Pages : 122
-
The global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market was valued at $XX million in 2019, and Research analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2020 and 2029.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this industry in 2020.
This report analyses the impact of COVID-19 on this industry. COVID-19 can affect the global market in 3 ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on enterprises and financial markets.
This report provides detailed historical analysis of global market for Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs from 2014-2019, and provides extensive market forecasts from 2020-2029 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market.
Leading players of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs including:
Astellas Pharmaceuticals
Actavis
Pfizer
GlaxoSmithKline
Salix Pharmaceuticals
AstraZenenca
Ironwood Pharmaceuticals
Allergan
Takeda Pharmaceutical
Sebela Pharmaceuticals
Synergy Pharmaceuticals
Synthetic Biologics
Bausch Health
Market split by Type, can be divided into:
Eluxadoline
Rifaximin
Alosetron
Loperamide
Diphenoxylate + Atropine
Market split by Application, can be divided into:
Rx
OTC
Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel
Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
-
With tables and figures helping analyze worldwide Report on Global Irritable Bowel Syndrome with Diarrhea market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Chapter 1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Overview1.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Definition
1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Status and Outlook (2014-2029)
1.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Comparison by Region (2014-2029)
1.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Comparison by Type (2014-2029)
1.5 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Comparison by Application (2014-2029)
1.6 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Comparison by Sales Channel (2014-2029)
1.7 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts on Current Market
1.7.5 Post-Strategies of COVID-19 Outbreak
Chapter 2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segment Analysis by Player2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Player (2017-2019)
2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Player (2017-2019)
2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Player (2017-2019)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segment Analysis by Type3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market by Type
3.1.1 Eluxadoline
3.1.2 Rifaximin
3.1.3 Alosetron
3.1.4 Loperamide
3.1.5 Diphenoxylate + Atropine3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type (2014-2019)
3.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Type (2014-2019)
3.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Type (2014-2019)
3.5 Leading Players of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type in 2019
3.6 Conclusion of Segment by Type
Chapter 4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segment Analysis by Application4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market by Application
4.1.1 Rx
4.1.2 OTC4.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Application (2014-2019)
4.3 Leading Consumers of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Application in 2019
4.4 Conclusion of Segment by Application
Chapter 5 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segment Analysis by Sales Channel5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Sales Channel (2014-2019)
5.3 Leading Distributors/Dealers of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Sales Channel in 2019
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segment Analysis by Region6.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and CAGR by Region (2014-2029)
6.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Region (2014-2019)
6.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Region (2014-2019)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type
6.4.3 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type
6.5.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type
6.6.3 Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type
6.7.3 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type
6.8.3 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players7.1 Astellas Pharmaceuticals
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.1.4 COVID-19 Impact on Astellas Pharmaceuticals7.2 Actavis
7.3 Pfizer
7.4 GlaxoSmithKline
7.5 Salix Pharmaceuticals
7.6 AstraZenenca
7.7 Ironwood Pharmaceuticals
7.8 Allergan
7.9 Takeda Pharmaceutical7.10 Sebela Pharmaceuticals
7.11 Synergy Pharmaceuticals
7.12 Synthetic Biologics
7.13 Bausch Health
Chapter 8 Upstream and Downstream Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs8.1 Industrial Chain of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
8.2 Upstream of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.2.4 Manufacturing Cost Structure
8.2.5 Manufacturing Process8.3 Downstream of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
8.3.1 Leading Distributors/Dealers of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
8.3.2 Leading Consumers of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Chapter 9 Development Trend of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (2020-2029)9.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (Sales and Revenue) Forecast (2020-2029)
9.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and CAGR Forecast by Region (2020-2029)
9.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and CAGR Forecast by Type (2020-2029)
9.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and CAGR Forecast by Application (2020-2029)
9.5 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and CAGR Forecast by Sales Channel (2020-2029)
Chapter 10 Appendix10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
-
The Report on Global Irritable Bowel Syndrome with Diarrhea Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
The Report on Global Irritable Bowel Syndrome with Diarrhea study includes a diverse group of participants, including both market leaders and up-and-comers. Contact our sales representative to receive a complete list of companies covered in the study.
The Report on Global Irritable Bowel Syndrome with Diarrhea Market study evaluates the year spans as follows: Historical year: 2018 to 2023; Base year: 2023; Forecast period**: 2024 to 2029 [** unless otherwise stated]
The convergence of various vital triggers, including a major slowdown in Western economies, and some critical points in globalization, leads to the transformation of business in the Report on Global Irritable Bowel Syndrome with Diarrhea Market across the extensive corporate landscape.
During the forecast years, the Report on Global Irritable Bowel Syndrome with Diarrhea Market can thrive with a robust CAGR.